Cookies Policy

To provide you with a better experience, InvestPorto, in collaboration with a number of partners, uses cookies on this website, which allow the personalization of content and advertising that is shown to you.
By continuing to use our website without changing your settings, we assume that you accept the use of cookies. Change Settings

Accept selected cookies Accept all cookies

University of Porto startup recognized as one of the 150 most promising in the world

University of Porto startup recognized as one of the 150 most promising in the world
02 Sep 2020

iLoF - Intelligent on Fibera University of Porto spin-off, is responsible for a patented technology that detects nanostructures in fluids. The start-up was distinguished in the area of ​​digital health.

Born at INESC TEC - Institute of Systems and Computers Engineering, Technology and Science, and currently installed at the Faculty of Medicine of the University of Porto (FMUP), iLoF is among the 150 most promising startups worldwide in the field of digital health, according to the list of CB Insights, an American company specializing in business analysis.

iLoF, which is being developed at Oxford Foundry, at the University of Oxford, was selected from a group of about 8,000 startups and is the only one with Portuguese DNA in this list, dominated mainly by North American companies (77%).

In order to reach this annual list, CB Insights collected several data, based on the investor profile, the market potential, the team analysis, and the technological novelty.

"It is an honor to be among the 150 most innovative and disruptive companies worldwide in the field of digital health. CB Insights' list is regularly recognized as one of the most reliable sources on trends and companies, this being another step in our mission to make it feasible. a new era of personalized medicine, helping the industry to develop, choose and democratize personalized treatments for patients around the world ", said Luís Valente, CEO of iLoF.

iLoF has stood out internationally for the development of patented technology for detecting nanostructures in fluids, through a virtual platform, digitizing and storing biological profiles of patients and biomarkers of diseases.

In July, the spin-off raised $ 1 million to finance three research projects, to be used to combat COVID-19, cancer, and Alzheimer's. 

In addition, she was recently nominated for the Portuguese Women In Tech awards, in the category of best national startup founded by a woman.